Early vasopressin reduces incidence of new onset arrhythmias

Journal of Critical Care

Volumn 29, Issue 4, 2014, Pages 482-485

  Reardon, David P ^a   DeGrado, Jeremy R ^a   Anger, Kevin E ^a   Szumita, Paul M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Catecholamine; Sepsis; Septic shock; Vasopressin

Indexed keywords

ADRENALIN; ARGIPRESSIN; CATECHOLAMINE; DOPAMINE; NORADRENALIN; PHENYLEPHRINE; VASOPRESSIN DERIVATIVE;

ADULT; ARTICLE; COHORT ANALYSIS; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG EFFECT; EARLY INTERVENTION; FEMALE; HEART ARRHYTHMIA; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; RETROSPECTIVE STUDY; SEPTIC SHOCK; THERAPY DELAY; TREATMENT DURATION; TREATMENT RESPONSE; AGED; ARRHYTHMIAS, CARDIAC; CRITICAL ILLNESS; DRUG ADMINISTRATION; MIDDLE AGED; SHOCK, SEPTIC;

AGED; ARGININE VASOPRESSIN; ARRHYTHMIAS, CARDIAC; CATECHOLAMINES; CRITICAL ILLNESS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HOSPITAL MORTALITY; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SHOCK, SEPTIC; VASOPRESSINS;

EID: 84902276605     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2014.03.005     Document Type: Article

References (20)

1. Lam S., Bauer S., Guzman J.A. Septic shock: the initial moments and beyond. Cleve Clin J Med 2013, 80(3):175-184.
2. Hollenberg S.M. Vasoactive drugs in circulatory shock. Am J Respir Crit Care Med 2011, 183:847-855.
3. Rivers E.P., Katranji M., Jaehne K.A., Brown S., Abou Dagher G., Cannon C., et al. Early interventions in severe sepsis and septic shock: a review of the evidence one decade later. Minerva Anestesiol 2012, 78:712-724.
4. Dellinger R.P., Levy M.M., Rhodes A., Annane D., Gerlach H., Gopal S.M., et al. Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012. Intensive Care Med 2013, 39:165-228.
5. Sadaka F., Juarez M., Naydenov S., O'Brien J. Fluid resuscitation in septic shock: the effect of increasing fluid balance on mortality. J Intensive Care Med 2013, [epub ahead of print].
6. Sharman A., Low J. Vasopressin and its role in critical care. Br J Anaesth 2008, 8(4):134-137.
7. Kampmeier T.G., Rehberg S., Westphal M., Lange M. Vasopressin in sepsis and septic shock. Minerva Anestesiol 2010, 76:844-850.
8. Barrett L.K., Singer M., Clapp L.H. Vasopressin: mechanisms of action on the vasculature in health and in septic shock. Crit Care Med 2007, 35(1):33-40.
9. Sharshar T., Blanchard A., Paillard M., Raphael J.C., Gajdos P., Annane D. Circulating vasopressin levels in septic shock. Crit Care Med 2003, 31(6):1752-1758.
10. Holmes C.L., Patel B.M., Russell J.A., Walley K.R. Physiology of vasopressin relevant to management of septic shock. Chest 2001, 120:989-1002.
11. Szumita P.M., Enfanto C.M., Greenwood B., Wechsler M.E. Vasopressin for vasopressor-dependent septic shock. Am J Health Syst Pharm 2005, 62:1931-1936.
12. Patel B.M., Chittock D.R., Russell J.A., Walley K.R. Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 2002, 96:576-582.
13. Serpa Neto A., Nassar A.P., Cardoso S.O., Manetta J.A., Pereira V.G., Esposito D.C., et al. Vasopressin and terlipressin in adult vasodilatory shock: a systematic review and meta-analysis of nine randomized controlled trials. Crit Care 2012, 16(4):R154.
14. Russell J.A., Walley K.R., Singer J., Gordon A.C., Hebert P.C., Cooper D.J., et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008, 358(9):877-887.
15. DeBacker D., Biston P., Devriendt J., Madl C., Chochrad D., Aldecoa C., et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 2010, 362(9):779-789.
16. Meierhenrich R., Steinhilber E., Eggerman C., Weiss M., Voglic S., Bogelein D., et al. Incidence and prognostic impact of new-onset atrial fibrillation in patients with septic shock: a prospective observational study. Crit Care 2010, 14:R108. 1-8.
17. Russell J.A. Bench-to-bedside review: vasopressin in the management of septic shock. Crit Care 2011, 15:1-19.
18. Daley M.J., Lat I., Mieure K.D., Jennings H.R., Hall J.B., Kress J.P. A comparison of initial monotherapy with norepinephrine versus vasopressin for resuscitation of septic shock. Ann Pharmacother 2013, 47:301-310.
19. Hall L.G., Oyen L.J., Taner B., Cullinane D.C., Baird T.K., Cha S.S., et al. Fixed-dose vasopressin compared with titrated dopamine and norepinephrine as initial vasopressor therapy for septic shock. Pharmacotherapy 2004, 24(8):1002-1012.
20. Mehta S., Granton J., Gordon A.C., Cook D.J., Lapinsky S., Newton G., et al. Cardiac ischemia in patients with septic shock randomized to vasopressin or norepinephrine. Crit Care 2013, 17(3):R117. 1-10.